Despite these limitations, this unique cellular model, which can display HDAC-mediated up- or downregulation of ABCB1 gene according to resistance status, appears therefore useful for effective design of agents to reverse MDR in cancer patients. The gene discussed is HDAC9; the disease is cancer.